Bisphosphonate induced hypocalcaemia – report of six cases and review of the literature

Intravenous bisphosphonates are widely used to treat osteoporosis and bone metastasis in cancer patients The risk of hypocalcaemia is a rare but underestimated side effect of anti-resorptive treatment. Clinically apparent hypocalcaemia is mostly related to high-dose treatment with zoledr...

Full description

Bibliographic Details
Main Authors: Veronika Kreutle, Claudine Blum, Christian Meier, Miriam Past, Beat Müller, Philipp Schütz, Katrin Borm
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2014-06-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/1876